肿瘤基础与临床
腫瘤基礎與臨床
종류기출여림상
JOURNAL OF BASIC AND CLINICAL ONCOLOGY
2014年
5期
392-394
,共3页
王保庆%张世强%薛青萍%王自全
王保慶%張世彊%薛青萍%王自全
왕보경%장세강%설청평%왕자전
晚期胃癌%化疗%全身热疗
晚期胃癌%化療%全身熱療
만기위암%화료%전신열료
advanced gastric cancer%chemotherapy%whole body hyperthermia
目的:观察全身热疗联合DCF方案化疗治疗晚期胃癌的近期疗效及毒副反应。方法67例晚期胃癌患者随机分为治疗组(32例)和对照组(35例),2组患者均采用DCF方案全身化疗,化疗第1天在全麻状态下用ET-SPACE全身热疗系统进行全身加热时开始静脉给药。结果治疗组总有效率和生活质量提高率均高于对照组(P均<0.05);2组毒副反应发生率比较差异无统计学意义(P均>0.05)。结论全身热疗联合DCF方案化疗治疗晚期胃癌可以获得较好的近期疗效,改善患者的生活质量,且毒副反应未增加,值得临床进一步推广。
目的:觀察全身熱療聯閤DCF方案化療治療晚期胃癌的近期療效及毒副反應。方法67例晚期胃癌患者隨機分為治療組(32例)和對照組(35例),2組患者均採用DCF方案全身化療,化療第1天在全痳狀態下用ET-SPACE全身熱療繫統進行全身加熱時開始靜脈給藥。結果治療組總有效率和生活質量提高率均高于對照組(P均<0.05);2組毒副反應髮生率比較差異無統計學意義(P均>0.05)。結論全身熱療聯閤DCF方案化療治療晚期胃癌可以穫得較好的近期療效,改善患者的生活質量,且毒副反應未增加,值得臨床進一步推廣。
목적:관찰전신열료연합DCF방안화료치료만기위암적근기료효급독부반응。방법67례만기위암환자수궤분위치료조(32례)화대조조(35례),2조환자균채용DCF방안전신화료,화료제1천재전마상태하용ET-SPACE전신열료계통진행전신가열시개시정맥급약。결과치료조총유효솔화생활질량제고솔균고우대조조(P균<0.05);2조독부반응발생솔비교차이무통계학의의(P균>0.05)。결론전신열료연합DCF방안화료치료만기위암가이획득교호적근기료효,개선환자적생활질량,차독부반응미증가,치득림상진일보추엄。
Objective ToobservetheeffectandtoxicitiesofwholebodyhyperthermiacombinedwithDCFregi-menchemotherapyinthetreatmentofpatientswithadvancedgastriccancer.Methods Sixty-sevenpatientswith advanced gastric cancer were randomly divided into two groups. Thirty-two patients of the treatment group was trea-ted by DCF regimen combining with whole body hyperthermia on the first day,and 35 patients of the control group wastreatedwithDCFregimenalone.Results Theresponserateandqualityoflifeinthetreatmentgroupwerebet-ter than those in the control group(P<0. 05). There was no statistical difference in the toxicities between the two groups(P>0.05).Conclusion WholebodyhyperthermiacanenhancetheeffectofDCFregimenchemotherapy for patients with advanced gastric cancer,improve the quality of life,do not increase the toxicities of chemotherapy.